Chinese Journal of Respiratory and Critical Care Medicine
Supervisor：Ministry of Education of the People's Republic of ChinaSponsor：West China Medical Center & West China Hospital, Sichuan University Editor-in-chief：LIN Jiangtao / LIU Chuntao Publishing period：
Monthly
ISSN：1671-6205CN：51-1631/R
Citation：韓文雅, 常嬋, 吳呈霖, 王梅芳. 抗結核治療穩定吸收過程中并發肺栓塞一例. Chinese Journal of Respiratory and Critical Care Medicine, 2023, 22(12): 886-888. doi: Copy
Copyright ? the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
1.
Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016, 13(10): e1002152.
2.
Moran TJ. Autopsy incidence of pulmonary embolism in tuberculosis. Dis Chest, 1950, 18(2): 171-173.
3.
Dentan C, Epaulard O, Seynaeve D, et al. Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes. Clin Infect Dis, 2014, 58(4): 495-501.
4.
Purayil NK, Sirajudeen J, Al Arbi KM, et al. Venous Thromboembolism: An Unusual Presentation of Pulmonary Tuberculosis. Cureus, 2021, 13(3): e14092.
5.
Kumarihamy KW, Ralapanawa DM, Jayalath WA. A rare complication of pulmonary tuberculosis: a case report. BMC Res Notes, 2015, 8: 39.
6.
Chaudhary A, Desai U, Joshi JM. Venous thromboembolism due to hyperhomocysteinaemia and tuberculosis. Natl Med J India, 2017, 30(3): 139-141.
7.
Sharma A, Sharma V. Abdominal aortic thrombosis and tuberculosis: an uncommon association. Gastroenterol Rep (Oxf), 2014, 2(4): 311-312.
8.
White NW. Venous thrombosis and rifampicin. Lancet (London, England), 1989, 334(8660): 434-435.
9.
Alawad MJ, Albuni MK, Subahi EA, et al. Rifampicin-Induced Pulmonary Embolism: A Rare Side Effect. Cureus, 2021, 13(10): e18904.
Kvasnicka T, Malikova I, Zenahlikova Z, et al. Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions. Curr Drug Metab, 2017, 18(7): 636-642.
12.
Altena R, Van Roon E, Folkeringa R, et al. Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring. Haematologica, 2014, 99(2): e26-27.
1. Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016, 13(10): e1002152.
2. Moran TJ. Autopsy incidence of pulmonary embolism in tuberculosis. Dis Chest, 1950, 18(2): 171-173.
3. Dentan C, Epaulard O, Seynaeve D, et al. Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes. Clin Infect Dis, 2014, 58(4): 495-501.
4. Purayil NK, Sirajudeen J, Al Arbi KM, et al. Venous Thromboembolism: An Unusual Presentation of Pulmonary Tuberculosis. Cureus, 2021, 13(3): e14092.
5. Kumarihamy KW, Ralapanawa DM, Jayalath WA. A rare complication of pulmonary tuberculosis: a case report. BMC Res Notes, 2015, 8: 39.
6. Chaudhary A, Desai U, Joshi JM. Venous thromboembolism due to hyperhomocysteinaemia and tuberculosis. Natl Med J India, 2017, 30(3): 139-141.
7. Sharma A, Sharma V. Abdominal aortic thrombosis and tuberculosis: an uncommon association. Gastroenterol Rep (Oxf), 2014, 2(4): 311-312.
8. White NW. Venous thrombosis and rifampicin. Lancet (London, England), 1989, 334(8660): 434-435.
9. Alawad MJ, Albuni MK, Subahi EA, et al. Rifampicin-Induced Pulmonary Embolism: A Rare Side Effect. Cureus, 2021, 13(10): e18904.
11. Kvasnicka T, Malikova I, Zenahlikova Z, et al. Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions. Curr Drug Metab, 2017, 18(7): 636-642.
12. Altena R, Van Roon E, Folkeringa R, et al. Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring. Haematologica, 2014, 99(2): e26-27.
1/5
WeChat